Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 422

1.

Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics.

Luboldt W, Pinkert J, Matzky C, Wunderlich G, Kotzerke J.

Curr Drug Deliv. 2009 Jul;6(3):255-60.

PMID:
19604139
2.

Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma.

Wang SJ, Lin WY, Chen MN, Chi CS, Chen JT, Ho WL, Hsieh BT, Shen LH, Tsai ZT, Ting G, Mirzadeh S, Knapp FF Jr.

J Nucl Med. 1998 Oct;39(10):1752-7.

3.

Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.

Häfeli UO, Casillas S, Dietz DW, Pauer GJ, Rybicki LA, Conzone SD, Day DE.

Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):189-99.

PMID:
10219814
4.

Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals.

Chen FD, Hsieh BT, Wang HE, Ou YH, Yang WK, Whang-Peng J, Liu RS, Knapp FF, Ting G, Yen SH.

Nucl Med Biol. 2001 Oct;28(7):835-44.

PMID:
11578906
6.

Influence of colloid particle profile on sentinel lymph node uptake.

Núñez EG, Faintuch BL, Teodoro R, Wiecek DP, Martinelli JR, da Silva NG, Castanheira CE, Filho RS, Pasqualini R.

Nucl Med Biol. 2009 Oct;36(7):741-7. doi: 10.1016/j.nucmedbio.2009.04.009. Epub 2009 Jul 9.

PMID:
19720286
7.

Particle sizes of colloids to be used in sentinel lymph node radiolocalization.

Jimenez IR, Roca M, Vega E, García ML, Benitez A, Bajén M, Martín-Comín J.

Nucl Med Commun. 2008 Feb;29(2):166-72.

PMID:
18094639
8.

Labeling and biodistribution of different particle materials for radioembolization therapy with 188Re.

Wunderlich G, Pinkert J, Stintz M, Kotzerke J.

Appl Radiat Isot. 2005 May;62(5):745-50. Epub 2004 Dec 22.

PMID:
15763481
9.

Bioevaluation of (90)Y-labeled particles in animal model of arthritis.

Pandey U, Bapat K, Sarma HD, Dhami PS, Naik PW, Samuel G, Venkatesh M.

Ann Nucl Med. 2009 Jun;23(4):333-9. doi: 10.1007/s12149-009-0239-3. Epub 2009 May 13.

PMID:
19437098
10.

Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system.

Saikawa A, Nomura T, Yamashita F, Takakura Y, Sezaki H, Hashida M.

Pharm Res. 1996 Oct;13(10):1438-44.

PMID:
8899832
11.

Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy.

Wunderlich G, Pinkert J, Andreeff M, Stintz M, Knapp FF Jr, Kropp J, Franke WG.

Appl Radiat Isot. 2000 Jan;52(1):63-8.

PMID:
10670924
12.

[188Re]Rhenium sulfide suspension: a potential radiopharmaceutical for tumor treatment following intra-tumor injection.

Junfeng Y, Duanzhi Y, Xiaofeng M, Zili G, Jiong Z, Yongxian W, Knapp FF Jr.

Nucl Med Biol. 1999 Jul;26(5):573-9.

PMID:
10473197
13.

DA-7911, 188Rhenium-tin colloid, as a new therapeutic agent of rheumatoid arthritis.

Shin CY, Son M, Ko JI, Jung MY, Lee IK, Kim SH, Kim WB, Jeong JM, Song YW.

Arch Pharm Res. 2003 Feb;26(2):168-72.

PMID:
12643596
14.

Rhenium-188 microspheres: a new radiation synovectomy agent.

Wang SJ, Lin WY, Chen MN, Hsieh BT, Shen LH, Tsai ZT, Ting G, Chen JT, Ho WL, Mirzadeh S, Knapp FF Jr.

Nucl Med Commun. 1998 May;19(5):427-33.

PMID:
9853331
15.

186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.

Bao A, Goins B, Klipper R, Negrete G, Phillips WT.

J Nucl Med. 2003 Dec;44(12):1992-9.

16.

The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.

Kennel SJ, Woodward JD, Rondinone AJ, Wall J, Huang Y, Mirzadeh S.

Nucl Med Biol. 2008 May;35(4):501-14. doi: 10.1016/j.nucmedbio.2008.02.001. Epub 2008 Apr 3.

PMID:
18482688
17.

Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs.

Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG.

Inhal Toxicol. 2004 Jun;16(6-7):453-9.

PMID:
15204761
18.

Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.

Meléndez-Alafort L, Nadali A, Zangoni E, Banzato A, Rondina M, Rosato A, Mazzi U.

Nucl Med Biol. 2009 Aug;36(6):693-701. doi: 10.1016/j.nucmedbio.2009.04.006.

PMID:
19647176
19.
20.

Evaluation of 99mTc labelled poly lactic acid microspheres for diagnostic radioembolization.

Ergün EL, Ercan MT, Selek H, Kaş HS, Ruacan S, Unsal IS, Mutlu M.

J Microencapsul. 2000 Jul-Aug;17(4):509-18.

PMID:
10898090
Items per page

Supplemental Content

Write to the Help Desk